Platforms
Making life better with multiplex molecular diagnostics at the Point of Care
Life is better in so many ways when we can diagnose infectious diseases at the Point of Care. It is immediate, easier and more efficient. Decisions are made quicker, transmission is slowed and ultimately people suffer less.
CAPTURE-XT explained
Sample cleanup and pathogen concentration
Future development
A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.
Tuberculosis - the challenge
RISK6 explained
Simplified Workflow
Future development
A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.
A supercharged platform, with a fast workflow
A smooth user experience with an intuitive interface
A ready to use solution, with all its simplicity, accuracy and speed
A ton of tech behind every result, with intelligent multilingual software algorithms.
A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system
A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.
High quality multiplex PCR testing, as simple as a lateral flow test
A sustainable respiratory infection control solution with the quality of lab-based PCR testing
Results you can trust, with a simple procedure and reliable testing
Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.
In today’s healthcare environment, every patient expects a quick and accurate diagnosis. QuantuMDx offers an advanced solution that enables healthcare professionals to meet this challenge by addressing their clinical needs.
Our product portfolio has been designed for you to deliver fast, accurate and actionable results in approximately thirty minutes, with a hands-on time of less than one-minute per sample.
Our solution includes a rapid multiplex PCR platform and an expanding test menu.
We plan to expand the menu of tests for Q-POC™, adding a Sexually Transmitted Infections (STIs) panel, a Urinary Tract Infections panel (UTIs) and Tuberculosis (TB) panel among others, to the current assay portfolio.
If you would like to stay up to date with our developing product portfolio get in touch for more information.